These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23856713)

  • 1. Vaccination of healthy children against seasonal influenza: a European perspective.
    Heikkinen T; Tsolia M; Finn A
    Pediatr Infect Dis J; 2013 Aug; 32(8):881-8. PubMed ID: 23856713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of influenza vaccination in children: European perspective.
    Heikkinen T; Heinonen S
    Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
    Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
    Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.
    Esposito S; Marchisio P; Bosis S; Lambertini L; Claut L; Faelli N; Bianchi C; Colombo GL; Principi N
    Vaccine; 2006 Jan; 24(5):629-35. PubMed ID: 16157429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
    Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
    Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic impact of influenza on healthy children and their families.
    Principi N; Esposito S; Marchisio P; Gasparini R; Crovari P
    Pediatr Infect Dis J; 2003 Oct; 22(10 Suppl):S207-10. PubMed ID: 14551476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
    Nichol KL
    Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza cost and cost-effectiveness studies globally--a review.
    Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
    Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
    Uhart M; Bricout H; Clay E; Largeron N
    Hum Vaccin Immunother; 2016 Sep; 12(9):2259-68. PubMed ID: 27166916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review].
    Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
    Myers ER; Misurski DA; Swamy GK
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S128-40. PubMed ID: 21640230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical economics in the field of influenza--past, present and future.
    Szucs TD
    Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma.
    Teufel RJ; Basco WT; Simpson KN
    J Hosp Med; 2008 Mar; 3(2):134-41. PubMed ID: 18438789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.